<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0253664</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3010</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin. Genet.</journal-id>
<journal-title-group>
<journal-title>Clinical genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0009-9163</issn>
<issn pub-type="epub">1399-0004</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26661695</article-id>
<article-id pub-id-type="pmc">4873406</article-id>
<article-id pub-id-type="doi">10.1111/cge.12708</article-id>
<article-id pub-id-type="manuscript">NIHMS744726</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Assessment of PAX6 alleles in 66 families with aniridia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bobilev</surname>
<given-names>Anastasia M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDougal</surname>
<given-names>Margaret E.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>William L.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geisert</surname>
<given-names>Eldon E.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="author-notes" rid="FN3">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Netland</surname>
<given-names>Peter A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN4">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lauderdale</surname>
<given-names>James D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">§</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Neuroscience Division of the Biomedical and Health Sciences Institute, The University of Georgia, Athens, GA 30602, USA</aff>
<aff id="A2"><label>2</label>Department of Cellular Biology, The University of Georgia, Athens, GA 30602, USA</aff>
<aff id="A3"><label>3</label>Molecular Resource Center, The University of Tennessee Health Science Center, Memphis, TN 38163 USA</aff>
<aff id="A4"><label>4</label>Department of Ophthalmology in the Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, TN 38163 USA</aff>
<author-notes>
<corresp id="FN1"><label>§</label>Corresponding Author: Department of Cellular Biology, University of Georgia, Athens, GA 30602, USA, <email>jdlauder@uga.edu</email>, Ph. 706-542-7433, Fax: 706-542-4271</corresp>
<fn fn-type="present-address" id="FN2">
<label>*</label>
<p>Current Address: Emory University School of Medicine, 201 Dowman Drive, Atlanta, Georgia 30322, <email>mmcdoug@emory.edu</email></p>
</fn>
<fn fn-type="present-address" id="FN3">
<label>†</label>
<p>Current Address: Professor of Ophthalmology, Emory Eye Center, B5600 Clinic B, 1365B Clifton Road NE, Atlanta, GA 30322, <email>egeiser@emory.edu</email>, Ph. 404-778-4239</p>
</fn>
<fn fn-type="present-address" id="FN4">
<label>‡</label>
<p>Current Address: Vernah Scott Moyston Professor and Chair, Department of Ophthalmology University of Virginia School of Medicine, P.O. Box 800715, Charlottesville, VA 22908-0715, <email>pnetland@virginia.edu</email>, Ph. 434-982-1086</p>
</fn>
<fn id="FN5">
<p>Note: Taylor contact information: Ph 901-448-6165, <email>wtaylor@uthsc.edu</email></p>
</fn>
<fn fn-type="conflict" id="FN6">
<p>
<bold>
<underline>Conflict of Interest statement:</underline>
</bold>
</p>
<p>There are no conflicts of interest for any of the authors of this study. The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>89</volume>
<issue>6</issue>
<fpage>669</fpage>
<lpage>677</lpage>
<!--elocation-id from pubmed: 10.1111/cge.12708-->
<abstract>
<p id="P1">We report on <italic>PAX6</italic> alleles associated with a clinical diagnosis of classical aniridia in 81 affected individuals representing 66 families. Allelic variants expected to affect PAX6 function were identified in 61 families (76 individuals). Ten cases of sporadic aniridia (10 families) had complete (8 cases) or partial (2 cases) deletion of the <italic>PAX6</italic> gene. Sequence changes that introduced a premature termination codon into the open reading frame of <italic>PAX6</italic> occurred in 47 families (62 individuals). Three individuals with sporadic aniridia (3 families) had sequence changes (1 deletion, 2 run-on mutations) expected to result in a C-terminal extension. An intronic deletion of unknown functional significance was detected in one case of sporadic aniridia (1 family), but not in unaffected relatives. Within these 61 families, single nucleotide substitutions accounted for 30/61 (49%), indels for 23/61 (38%), and complete deletion of the <italic>PAX6</italic> locus for 8/61 (13%). In five cases of sporadic aniridia (5 families), no disease-causing mutation in the coding region was detected. In total, 27 unique variants were identified that have not been reported in the LOVD database. Within the group assessed, 92% had sequence changes expected to reduce PAX6 function, confirming the primacy of PAX6 haploinsufficiency as causal for aniridia.</p>
</abstract>
<kwd-group>
<kwd>Absent Iris</kwd>
<kwd>Eye Abnormalities</kwd>
<kwd>Eye Disease</kwd>
<kwd>Irideremia</kwd>
<kwd>chromosome 11p13</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>